Immunocore Holdings plc (IMCR) Misses Q4 EPS by 65c

Immunocore Holdings plc (NASDAQ: IMCR) reported Q4 EPS of ($0.63), $0.65 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $58 million versus the consensus estimate of $43.37 million.

For earnings history and earnings-related data on Immunocore Holdings plc (IMCR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c